Accueil > BIGG > Résultat de la recherche

    Résultats: 2

    Non-alcoholic fatty liver disease (NAFLD): assessment and management

    England. National Institute for Health and Care Excellence.
    This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced li...
    Stéatose hépatique non alcoolique/thérapie, Stéatose hépatique non alcoolique/traitement médicamenteux, Stéatose hépatique non alcoolique/diagnostic, Pioglitazone/usage thérapeutique, Vitamine E/usage thérapeutique, Cirrhose du foie/prévention et contrôle, Syndrome métabolique X/prévention et contrôle
    Texte intégral

    Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    Watanabe, S; Hashimoto, E; Ikejima, K; Uto, H; Ono, M; Sumida, Y; Seike, M; Takei, Y; Takehara, T; Tokushige, K; Nakajima, A; Yoneda, M; Saibara, T; Shiota, G; Sakaida, I; Nakamuta, M; Mizuta, T; Tsubouchi, H; Sugano, K; Shimosegawa, T.
    J. Gastroenterol; 50 (4), 2015
    Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, nonal...
    Stéatose hépatique non alcoolique/traitement médicamenteux, Thiazolidinediones/usage thérapeutique, Vitamine E/usage thérapeutique, Chirurgie bariatrique, Transplantation hépatique
    Texte intégral